Bioventus (BVS) Exchange Rate Effect (2020 - 2026)
Bioventus (BVS) posted Exchange Rate Effect of -$608000.0 for Q1 2026, down 557.14% on a QoQ basis from $133000.0 in Q4 2025, and down 241.4% year-over-year from $430000.0 in Q1 2025.
Bioventus (BVS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Bioventus' Exchange Rate Effect history runs 7 years deep, the most recent figure standing at -$608000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 241.4% year-over-year to -$608000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$667000.0 (up 57.94% YoY) and the FY2025 annual result came in at $371000.0, up 114.49% from the prior year.
- Exchange Rate Effect was -$608000.0 for Q1 2026 at Bioventus, down from $133000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$2.1 million in Q4 2024.
- A 5-year average of -$96882.4 and a median of -$71000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect surged 749.3% — and 2024, when it sank 660.6%.
- Bioventus' Exchange Rate Effect stood at $1.1 million in 2022, then sank by 65.02% to $368000.0 in 2023, then sank by 660.6% to -$2.1 million in 2024, then surged by 106.45% to $133000.0 in 2025, then slumped by 557.14% to -$608000.0 in 2026.
- Business Quant data shows BVS's Exchange Rate Effect at -$608000.0 in Q1 2026, $133000.0 in Q4 2025, and -$394000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -2.80 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -37.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 45.66 Mn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | -608,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -608,000.00 |
| Mar 28, 2026 | -608,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Dec 31, 2025 | 133,000.00 |
| Sep 27, 2025 | -394,000.00 |
| Sep 27, 2025 | -394,000.00 |
| Jun 28, 2025 | 202,000.00 |
| Jun 28, 2025 | 202,000.00 |
| Mar 29, 2025 | 430,000.00 |
| Mar 29, 2025 | 430,000.00 |
| Dec 31, 2024 | -2.06 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Sep 28, 2024 | 466,000.00 |
| Sep 28, 2024 | 466,000.00 |
| Jun 29, 2024 | -419,000.00 |
| Jun 29, 2024 | -419,000.00 |
| Mar 30, 2024 | -544,000.00 |
| Mar 30, 2024 | -544,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Dec 31, 2023 | 368,000.00 |